FHTX logo

Foghorn Therapeutics (FHTX) Revenue

Annual Revenue

$22.60 M
-$11.55 M-33.83%

December 1, 2024


Summary


Performance

FHTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFHTXprofitabilitymetrics:

Quarterly Revenue

$2.86 M
-$4.95 M-63.42%

December 1, 2024


Summary


Performance

FHTX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$22.60 M
-$2.91 M-11.42%

December 1, 2024


Summary


Performance

FHTX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFHTXprofitabilitymetrics:

FHTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.8%0.0%0.0%
3 y3 years+1613.6%-46.2%+9.6%
5 y5 years--46.2%+9.6%

FHTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.8%+1613.6%-83.7%+300.6%-35.8%+1613.6%
5 y5-year-33.8%+5156.3%-83.7%+6865.9%-35.8%>+9999.0%
alltimeall time-33.8%+5156.3%-83.7%+6865.9%-35.8%>+9999.0%

Foghorn Therapeutics Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$22.60 M(-33.8%)
$2.86 M(-63.4%)
$22.60 M(-11.4%)
Sep 2024
-
$7.81 M(+13.4%)
$25.52 M(-27.5%)
Jun 2024
-
$6.89 M(+36.4%)
$35.19 M(+3.8%)
Mar 2024
-
$5.05 M(-12.5%)
$33.90 M(-0.8%)
Dec 2023
$34.16 M(+77.6%)
$5.77 M(-67.0%)
$34.16 M(+4.9%)
Sep 2023
-
$17.48 M(+212.2%)
$32.57 M(+49.9%)
Jun 2023
-
$5.60 M(+5.5%)
$21.73 M(+5.4%)
Mar 2023
-
$5.31 M(+26.9%)
$20.62 M(+7.2%)
Dec 2022
$19.23 M
$4.18 M(-36.9%)
$19.23 M(+22.0%)
DateAnnualQuarterlyTTM
Sep 2022
-
$6.63 M(+47.8%)
$15.76 M(+71.9%)
Jun 2022
-
$4.49 M(+14.5%)
$9.16 M(+85.0%)
Mar 2022
-
$3.92 M(+449.8%)
$4.95 M(+275.5%)
Dec 2021
$1.32 M(+206.7%)
$713.00 K(+1639.0%)
$1.32 M(+53.9%)
Sep 2021
-
$41.00 K(-85.3%)
$857.00 K(-13.9%)
Jun 2021
-
$279.00 K(-2.4%)
$995.00 K(+39.0%)
Mar 2021
-
$286.00 K(+13.9%)
$716.00 K(+66.5%)
Dec 2020
$430.00 K
$251.00 K(+40.2%)
$430.00 K(+140.2%)
Sep 2020
-
$179.00 K
$179.00 K

FAQ

  • What is Foghorn Therapeutics annual revenue?
  • What is the all time high annual revenue for Foghorn Therapeutics?
  • What is Foghorn Therapeutics annual revenue year-on-year change?
  • What is Foghorn Therapeutics quarterly revenue?
  • What is the all time high quarterly revenue for Foghorn Therapeutics?
  • What is Foghorn Therapeutics quarterly revenue year-on-year change?
  • What is Foghorn Therapeutics TTM revenue?
  • What is the all time high TTM revenue for Foghorn Therapeutics?
  • What is Foghorn Therapeutics TTM revenue year-on-year change?

What is Foghorn Therapeutics annual revenue?

The current annual revenue of FHTX is $22.60 M

What is the all time high annual revenue for Foghorn Therapeutics?

Foghorn Therapeutics all-time high annual revenue is $34.16 M

What is Foghorn Therapeutics annual revenue year-on-year change?

Over the past year, FHTX annual revenue has changed by -$11.55 M (-33.83%)

What is Foghorn Therapeutics quarterly revenue?

The current quarterly revenue of FHTX is $2.86 M

What is the all time high quarterly revenue for Foghorn Therapeutics?

Foghorn Therapeutics all-time high quarterly revenue is $17.48 M

What is Foghorn Therapeutics quarterly revenue year-on-year change?

Over the past year, FHTX quarterly revenue has changed by $0.00 (0.00%)

What is Foghorn Therapeutics TTM revenue?

The current TTM revenue of FHTX is $22.60 M

What is the all time high TTM revenue for Foghorn Therapeutics?

Foghorn Therapeutics all-time high TTM revenue is $35.19 M

What is Foghorn Therapeutics TTM revenue year-on-year change?

Over the past year, FHTX TTM revenue has changed by $0.00 (0.00%)